Edgar Forche - Concepedia

Author

Edgar Forche

Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien

Also Known As

E. FORCHE, E. Forche, EDGAR FORCHE, Edgar FORCHE, Edgar Forche, Forche, E.

Publications

875

Citations

H-Index

Concepts

All Affiliations

Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien German Primate Center Helmholtz Centre for Infection Research

About

Edgar Forche is an author at Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	521
2	Biochemistry	9	9	582
3	Natural Sciences	8	8	498
4	Engineering	1	1	13
5	Health Sciences	1	1	51

Edgar Forche

Publications

723

Citations

H-Index

Page 1

	Year	Citations
Two binding sites of inhibitors in NADH:ubiquinone oxidoreductase (complex I) Thorsten Friedrich, Petra van Heek, Hans Leif, European Journal of Biochemistry Inhibitory ActivityBiochemistryNatural SciencesMedicineBovine Heart	1994	250
Formation of Benzophenanthridine Alkaloids by Suspension Cultures of Eschscholtzia californica Jochen Berlin, Edgar Forche, Victor Wray, Zeitschrift für Naturforschung C BiosynthesisBioorganic ChemistryBiochemistryNatural SciencesInduction Medium Im2	1983	70
Melithiazols, New .BETA.-Methoxyacrylate Inhibitors of the Respiratory Chain Isolated from Myxobacteria. Production, Isolation, Physico-chemical and Biological Properties. Florenz Sasse, Bettina Böhlendorf, Martina Hermann, The Journal of Antibiotics	1999	55
Antibiotics from Gliding Bacteria, LXXVI. Vioprolides: New Antifungal and Cytotoxic Peptolides from <i>Cystobacter violaceus</i> Dietmar Schummer, Gerhard Höfle, Edgar Forche, Liebigs Annalen Bioorganic ChemistryAmino AcidsAntimicrobial ChemotherapyAntimicrobial TherapyAntimicrobial Resistance	1996	51
Melithiazols A–N: New Antifungal β‐Methoxyacrylates from Myxobacteria Bettina Böhlendorf, Martina Herrmann, Hans‐Jürgen Hecht, European Journal of Organic Chemistry Melithiazols A–nIndustrial MycologyAntifungal AgentBioorganic ChemistryBiochemistry	1999	48
Antibiotika aus Gleitenden Bakterien, 45. Phenalamide, neue HIV‐1‐Inhibitoren aus <i>Myxococcus stipitatus</i> Mx s40 Wolfram Trowitzsch‐Kienast, Edgar Forche, Victor Wray, Liebigs Annalen der Chemie Bioorganic ChemistryAntimicrobial ChemotherapyAntiviral DrugNew Hiv‐1 InhibitorsChemical Biology	1992	47
Antibiotics from Gliding Bacteria, LXXIII Indole and Quinoline Derivatives as Metabolites of Tryptophan in Myxobacteria Bettina Böhlendorf, Norbert Bedorf, Rolf Jansen, Liebigs Annalen Antimicrobial Drug DiscoveryAntifungal AgentAntibioticsBiochemistryIndole 1	1996	43
Three New Potent HIV-1 Inhibitors from Myxobacteria Elke Jurkiewicz, Rolf Jansen, Brigitte Kunze, Antiviral chemistry & chemotherapy Medicinal ChemistryMedicineHuman RetrovirusHiv-1 Rt ActivityHiv-1 Replication	1992	42
Biosynthesis of Myxothiazol Z, the Ester-analog of Myxothiazol A in Myxococcus fulvus Heinrich Steinmetz, Edgar Forche, Hans Reichenbach, Tetrahedron Industrial MycologyBiosynthesisBioorganic ChemistryBiochemistryNatural Sciences	2000	29
Isolation, Biological Activity Evaluation, Structure Elucidation, and Total Synthesis of Eliamid: A Novel Complex I Inhibitor Gerhard Höfle, Klaus Gerth, Hans Reichenbach, Chemistry - A European Journal Medicinal ChemistryTetramic Acid AmideBiochemistryAntiparasitic AgentNatural Sciences	2012	23

Page 1